PATENT CLAIM ANALYSIS

Application Number: 15893542
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "465000"]

Abstract:
In one aspect, compositions and methods for the treatment of vulvovaginal atrophy (VVA) are provided. In one embodiment, the method comprises administering an estrogen to a subject having VVA by inserting a dosage form comprising a liquid pharmaceutical composition.

Claim (Index 2):
The method of  claim 1 , wherein the one or more symptoms of VVA are selected from the group consisting of vaginal dryness, vaginal odor, vaginal or vulvar irritation, dysuria, dyspareunia, vaginal bleeding associated with sexual activity, vaginal soreness with urinary frequency and urgency, urinary discomfort, incontinence, and increased vaginal pH.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 88.0
- Lexical Diversity: 1.21622
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15893546', '15372385', '15893550', '14521230', '14624051']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8370472496932084
- 35 USC 102 Novelty (BERT): 0.6559763571945817
- Combined Prediction Score: 0.8189401604433458
- Mean Citation Score: 548.485278
- Max Citation Score: 680.72253
- Similarity Product: 617.7637491470969

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test